Tech View: Nothing to fear from Crispr – in the right hands
The genetic editing tool, whose makers were awarded a Nobel Prize last week, is only as dangerous as the people using it
Science and technology are neither good nor evil. They just are. We decide what will come from discovery. We decide what we won’t allow such discoveries to be used for.
This has become more important to acknowledge in recent days following the awarding of the Nobel Prize in Chemistry to Emmanuelle Charpentier and Jennifer A Doudna for their work on Crispr, a genetic editing tool.
The fears that come just from those last...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Is invitation-only Clubhouse just all talk?
Just like Zoom this time last year, the much-hyped app is in position to become a household name in a hurry – but it too faces some real questions
Tech View: Is space your next frontier? Then read on
Do you remain calm under pressure, can you cope with irregular hours, lots of travel and time away from your family? If the answer is yes, then you could be on your way to becoming an astronaut
Explainer: What’s happening with Google and Facebook in Australia, and what does it mean for us?
The tech giants have reacted wildly differently to the Australian government’s pressure to force them to pay media companies but this is far from a simple story
Tech View: Netflix’s price hike is a gamble as our choice grows
The streaming giant is taking a risk by raising its tariffs just as other hugely-resourced competitors are upping their game
